Do Overactive Bladder Drugs Raise Dementia Risk? A Big New Study Challenges the Fear
Overactive bladder affects millions of people, especially women and older adults. For years, patients have been warned that a common class of bladder medicines called anticholinergics, which includes oxybutynin, might raise the risk of dementia. A large new study suggests that worry may have been overstated.
The study
Researchers at University Hospitals Cleveland Medical Center analyzed electronic health records for 830,393 adults aged 40 to 90 who started treatment for overactive bladder between 2012 and 2025. They compared three groups (PubMed):
- “High-risk” anticholinergics: oxybutynin, tolterodine, solifenacin
- “Low-risk” anticholinergics: darifenacin, trospium, fesoterodine
- Beta-3 agonists, the newer class thought to be safer for the brain: mirabegron, vibegron
The study was published in JAMA Network Open.
What they found
Contrary to expectations, the newer beta-3 agonists were not linked to less dementia. The estimated 10-year dementia risk was 20.0% for beta-3 agonists and 18.1% for the high-risk anticholinergics. Taking anticholinergics for longer was also not linked to higher risk (PubMed).
The authors say earlier findings of higher risk may reflect differences between patients rather than a direct effect of the drugs.
A possible explanation
Researchers suggest that overactive bladder itself may sometimes be an early sign of the brain changes that lead to dementia. If so, bladder symptoms could one day help doctors spot dementia earlier (Medical Xpress).
Not the final word
The debate is far from settled:
- This was an observational study, and the authors note the differences could be explained by unmeasured factors (PubMed).
- It did not include people who took no medication, so it cannot show that these drugs carry no risk (Medical Xpress).
- A separate meta-analysis of 13 studies published the same week linked anticholinergic use to higher dementia risk, especially in the first three years (Age and Ageing).
- The lead author says beta-3 agonists are still the better choice whenever possible.
What this means for you
If you take an anticholinergic for your bladder and it helps, do not stop suddenly out of fear. Review your options with your doctor, especially if you are older or take other medicines with similar effects. Short-term memory side effects can happen with these drugs but usually go away when the medication is stopped.
